Loading Video…
This browser does not support the Video element.
Pfizer seeks FDA authorization of COVID-19 vaccine for kids 5 to 11
Pfizer and BioNTech on Thursday announced that they have formally submitted a request to U.S. regulators for emergency approval of their COVID-19 vaccine for children ages 5 to 11.